Pharma News

Squaric acid dibutyl ester by Squarex Pharmaceutical for Herpes Labialis (Oral Herpes): Likelihood of Approval

Squaric acid dibutyl ester is under clinical development by Squarex Pharmaceutical and currently in Phase I for Herpes Labialis (Oral Herpes).

Source link
#Squaric #acid #dibutyl #ester #Squarex #Pharmaceutical #Herpes #Labialis #Oral #Herpes #Likelihood #Approval

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *